Smart Insoles for Improving Sensation, Balance and Mobility in People with Diabetic Peripheral Neuropathy.
Pathfeel
Investigating the Efficacy of Foot Sole Vibration on Balance and Physical Activity in People with Diabetic Peripheral Neuropathy.
1 other identifier
interventional
19
1 country
1
Brief Summary
The long-term effects of vibrating insoles on improving gait, balance and peripheral sensation in people with diabetic peripheral neuropathy remain unknown. The Pathfeel Clinical Trial will investigate the efficacy of vibratory insoles worn for ten days for enhancing sensory perception, gait quality, balance and physical activity in people with mild to severe diabetic neuropathy. The primary outcome will be changes in gait speed and postural and dynamic balance.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable diabetes-mellitus
Started Oct 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2023
CompletedFirst Submitted
Initial submission to the registry
November 25, 2024
CompletedFirst Posted
Study publicly available on registry
March 3, 2025
CompletedMarch 3, 2025
February 1, 2025
1.1 years
November 25, 2024
February 28, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Postural Balance
Centre-of-pressure velocity will be assessed using a force platform.
Measurements were taken at four time points: at baseline, after 10 days of the first vibratory intervention, after a 10-day washout period, and at the end of the 10-day second vibratory intervention.
Gait speed during walking
Gait speed during level and stair walking will be assessed by 3D Motion Capture system.
Measurements were taken at four time points: at baseline, after 10 days of the first vibratory intervention, after a 10-day washout period, and at the end of the 10-day second vibratory intervention.
Secondary Outcomes (2)
Peripheral Sensation
Measurements were taken at four time points: at baseline, after 10 days of the first vibratory intervention, after a 10-day washout period, and at the end of the 10-day second vibratory intervention.
Peripheral Sensation 2
Measurements were taken at four time points: at baseline, after 10 days of the first vibratory intervention, after a 10-day washout period, and at the end of the 10-day second vibratory intervention.
Study Arms (2)
Vibration
ACTIVE COMPARATORInsoles with vibration
No Vibration
PLACEBO COMPARATORInsoles without vibration
Interventions
Sole vibration will be applied by a vibrating insole system for 10 days. Participants will wear the device for at least 4 hours per day.
Participants will wear the device with vibration turned off for at least 4 hours per day during 10 days of intervention.
Eligibility Criteria
You may qualify if:
- Diagnosis of diabetes type 1 or 2
- ≥1 palpable foot pulses
- Presence of mild to moderate diabetic peripheral neuropathy defined by a vibration perception threshold ≥15 Volts and/or mNDS score ≥3.
- Aged ≥ 18 years
- Ability to walk unaided for 30 steps
- Able to understand the study requirements
- Ability to check their feet regularly (or have another person check).
- Able to read the study documents
- Fit shoe size EU 36-47.5 / UK 3.5-13.
You may not qualify if:
- Active foot ulcer
- Lower limb amputation (anything more than amputation of two lesser toes)
- Presence of Charcot deformity
- Dementia or other cognitive impairment
- Significant cardiopulmonary or other systemic disease limiting the patient's ability to walk 30 steps.
- Person's with bodyweight greater than 130kg (due to insole device limitations)
- Presence of implantable neurostimulators
- Presence of a pacemaker.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Walk With Pathlead
- Manchester Metropolitan Universitycollaborator
Study Sites (1)
Manchester Metropolitan University
Manchester, M15GD, United Kingdom
Related Publications (1)
Orlando G, Brown S, Jude E, Bowling FL, Boulton AJM, Reeves ND. Acute Effects of Vibrating Insoles on Dynamic Balance and Gait Quality in Individuals With Diabetic Peripheral Neuropathy: A Randomized Crossover Study. Diabetes Care. 2024 Jun 1;47(6):1004-1011. doi: 10.2337/dc23-1858.
PMID: 38536962BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Neil D. Reeves, PhD, Professor
Lancaster University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 25, 2024
First Posted
March 3, 2025
Study Start
October 1, 2022
Primary Completion
November 1, 2023
Study Completion
November 30, 2023
Last Updated
March 3, 2025
Record last verified: 2025-02
Data Sharing
- IPD Sharing
- Will not share
There is not a plan to make IPD available.